In accordance with the ‘Drug Approval Change Order’ (Drug Review and Coordination Division-No. 2171, effective date 2017. 04. 05), the precautions for use of Inhipla Tablet have been changed.


For further details, please refer to the ‘Product Introduction’ section and attached documents.